enGene Holdings Inc Common Stock
Price & Volume
Stats
See more52W Range | $1.40-$12.25 |
Market Cap | $109.8M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.25 |
News
See moreYahoo Finance • 5 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of enGene Therapeutics Inc. - ENGN
Yahoo Finance • 9 days ago
Why This Fund Made a $66 Million Bet on Damora Therapeutics Amid a 700% Surge
Yahoo Finance • 9 days ago
Dyne Stock Is Up 56%. Here's What a $14 Million Stake Reduction Could Mean
Yahoo Finance • 28 days ago
Leerink Partners Lifts PT on Oruka Therapeutics, Inc. (ORKA)
About
CEO | Mr. Ronald H. W. Cooper |
CFO | Mr. David Ryan Daws |
Address | 4868 Rue Levy, Montreal, QC, Canada, H4R 2P1 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 81 |